{"transactions":[{"id":758640,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Corp Controller"}}],"security":"Restricted Stock Unit","published_at":"2026-05-29T20:16:13.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on March 1, 2027, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting Person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on March 1, 2027, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting Person's continued service through such vesting date."}],"balance_after":20000,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001434647-26-000037","document":"wk-form4_1780085770.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143464726000037/wk-form4_1780085770.xml","form_type":"4"}},{"id":758639,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Corp Controller"}}],"security":"Stock Option (right to buy)","published_at":"2026-05-29T20:16:13.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the \"Plan\"). The option will vest and become exercisable in four equal annual installments beginning on March 1, 2027, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":11.4,"expiration_date":"2036-05-27","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001434647-26-000037","document":"wk-form4_1780085770.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143464726000037/wk-form4_1780085770.xml","form_type":"4"}},{"id":919307,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Corp Controller"}}],"security":"Common Stock","published_at":"2026-02-04T21:27:22.000Z","date":"2026-02-03","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":9.1827,"value":27548.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 3/28/2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $8.93 to $9.52. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":29590,"source":{"system":"sec-edgar","filing":"0001698328-26-000004","document":"wk-form4_1770240439.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000169832826000004/wk-form4_1770240439.xml","form_type":"4"}},{"id":924836,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Corp Controller"}}],"security":"Restricted Stock Unit","published_at":"2026-02-02T22:19:58.000Z","date":"2026-01-31","kind":"exercise","planned":true,"acquired":false,"shares":11666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One third of the restricted stock units vested and settled on each of January 31, 2025 and January 31, 2026. The remaining one third of the shares will vest and settle on January 31, 2027, subject to the Reporting person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"One third of the restricted stock units vested and settled on each of January 31, 2025 and January 31, 2026. The remaining one third of the shares will vest and settle on January 31, 2027, subject to the Reporting person's continued service through such vesting date."}],"balance_after":11668,"derivative":{"underlying":"Common Stock","underlying_shares":11666},"source":{"system":"sec-edgar","filing":"0001698328-26-000002","document":"wk-form4_1770070795.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000169832826000002/wk-form4_1770070795.xml","form_type":"4"}},{"id":924835,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Corp Controller"}}],"security":"Restricted Stock Unit","published_at":"2026-02-02T22:19:58.000Z","date":"2026-01-30","kind":"exercise","planned":true,"acquired":false,"shares":6333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One third of the restricted stock units vested and settled on January 30, 2026. The remaining two thirds of the shares will vest and settle in equal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"One third of the restricted stock units vested and settled on January 30, 2026. The remaining two thirds of the shares will vest and settle in equal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date."}],"balance_after":12667,"derivative":{"underlying":"Common Stock","underlying_shares":6333},"source":{"system":"sec-edgar","filing":"0001698328-26-000002","document":"wk-form4_1770070795.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000169832826000002/wk-form4_1770070795.xml","form_type":"4"}},{"id":924834,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Corp Controller"}}],"security":"Common Stock","published_at":"2026-02-02T22:19:58.000Z","date":"2026-01-31","kind":"exercise","planned":true,"acquired":true,"shares":11666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":32590,"source":{"system":"sec-edgar","filing":"0001698328-26-000002","document":"wk-form4_1770070795.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000169832826000002/wk-form4_1770070795.xml","form_type":"4"}},{"id":924833,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Corp Controller"}}],"security":"Common Stock","published_at":"2026-02-02T22:19:58.000Z","date":"2026-01-30","kind":"sale","planned":true,"acquired":false,"shares":1750,"price":8.824,"value":15442.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Adoption date of referenced 10b5-1(c) plan is: 3/28/2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $8.62 to $8.995. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":20924,"source":{"system":"sec-edgar","filing":"0001698328-26-000002","document":"wk-form4_1770070795.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000169832826000002/wk-form4_1770070795.xml","form_type":"4"}},{"id":924832,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Corp Controller"}}],"security":"Common Stock","published_at":"2026-02-02T22:19:58.000Z","date":"2026-01-30","kind":"exercise","planned":true,"acquired":true,"shares":6333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":22674,"source":{"system":"sec-edgar","filing":"0001698328-26-000002","document":"wk-form4_1770070795.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000169832826000002/wk-form4_1770070795.xml","form_type":"4"}},{"id":1267158,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"officer":true,"officer_title":"SVP, Finance & Corp Controller"}}],"security":"Common Stock","published_at":"2025-02-14T22:57:04.000Z","date":"2025-02-13","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":7.8626,"value":23587.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 10-15-2024"}],"balance_after":16341,"source":{"system":"sec-edgar","filing":"0001437749-25-004070","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925004070/rdgdoc.xml","form_type":"4"}},{"id":1287258,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"officer":true,"officer_title":"SVP, Finance & Corp Controller"}}],"security":"Restricted Stock Unit","published_at":"2025-02-03T22:24:37.000Z","date":"2025-01-30","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on January 30, 2026, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on January 30, 2026, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's continued service through such vesting date."}],"balance_after":19000,"derivative":{"underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001437749-25-002629","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925002629/rdgdoc.xml","form_type":"4"}},{"id":1287257,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"officer":true,"officer_title":"SVP, Finance & Corp Controller"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-03T22:24:37.000Z","date":"2025-01-30","kind":"grant","planned":false,"acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the \"Plan\"). The option will vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant."}],"balance_after":38000,"derivative":{"exercise_price":8.02,"expiration_date":"2035-01-29","underlying":"Common Stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001437749-25-002629","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925002629/rdgdoc.xml","form_type":"4"}},{"id":1287256,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"officer":true,"officer_title":"SVP, Finance & Corp Controller"}}],"security":"Restricted Stock Unit","published_at":"2025-02-03T22:24:37.000Z","date":"2025-01-31","kind":"exercise","planned":false,"acquired":false,"shares":11666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The first tranche of the restricted stock units vested and settled on January 31, 2025, and the remaining two tranches of the restricted stock units will vest and settle inequal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The first tranche of the restricted stock units vested and settled on January 31, 2025, and the remaining two tranches of the restricted stock units will vest and settle inequal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date."}],"balance_after":23334,"derivative":{"underlying":"Common Stock","underlying_shares":11666},"source":{"system":"sec-edgar","filing":"0001437749-25-002629","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925002629/rdgdoc.xml","form_type":"4"}},{"id":1287255,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"officer":true,"officer_title":"SVP, Finance & Corp Controller"}}],"security":"Common Stock","published_at":"2025-02-03T22:24:37.000Z","date":"2025-01-31","kind":"exercise","planned":false,"acquired":true,"shares":11666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":19341,"source":{"system":"sec-edgar","filing":"0001437749-25-002629","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925002629/rdgdoc.xml","form_type":"4"}},{"id":1661486,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Restricted Stock Unit","published_at":"2024-02-03T01:17:46.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. \t Grant to the Reporting Person of restricted stock units (\"RSU\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on January 31, 2025, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's ongoing employment."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on January 31, 2025, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's ongoing employment."}],"balance_after":35000,"derivative":{"underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001437749-24-003031","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774924003031/rdgdoc.xml","form_type":"4"}},{"id":1956648,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2023-03-13T11:57:22.000Z","date":"2023-03-10","kind":"purchase","acquired":true,"shares":100,"price":4.135,"value":413.5,"ownership":{"direct":true},"balance_after":4449,"source":{"system":"sec-edgar","filing":"0001437749-23-006278","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774923006278/rdgdoc.xml","form_type":"4"}},{"id":1956647,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2023-03-13T11:57:22.000Z","date":"2023-03-10","kind":"purchase","acquired":true,"shares":1100,"price":4.1397,"value":4553.67,"ownership":{"direct":true},"balance_after":4349,"source":{"system":"sec-edgar","filing":"0001437749-23-006278","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774923006278/rdgdoc.xml","form_type":"4"}},{"id":2056415,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-12T02:45:50.000Z","date":"2023-01-09","kind":"grant","acquired":true,"shares":136986,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the \"Plan\"). 25% of the shares will vest on January 6, 2024 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant."}],"balance_after":136986,"derivative":{"exercise_price":4.54,"expiration_date":"2033-01-08","underlying":"Common Stock","underlying_shares":136986},"source":{"system":"sec-edgar","filing":"0001437749-23-000913","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774923000913/rdgdoc.xml","form_type":"4"}},{"id":2413566,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-03T22:17:39.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":50092,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the \"Plan\"). 25% of the shares will vest on February 1, 2023 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant."}],"balance_after":50092,"derivative":{"exercise_price":7.17,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":50092},"source":{"system":"sec-edgar","filing":"0001437749-22-002401","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774922002401/rdgdoc.xml","form_type":"4"}},{"id":2592135,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-24T20:27:39.000Z","date":"2021-08-20","kind":"grant","acquired":true,"shares":44023,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the \"Plan\"). 25% of the shares will vest on August 20, 2022 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant."}],"balance_after":44023,"derivative":{"exercise_price":9.06,"expiration_date":"2031-08-19","underlying":"Common Stock","underlying_shares":44023},"source":{"system":"sec-edgar","filing":"0001437749-21-020859","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774921020859/rdgdoc.xml","form_type":"4"}},{"id":3208701,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2020-03-17T00:04:05.000Z","date":"2020-03-13","kind":"purchase","acquired":true,"shares":4000,"price":0.2,"value":800.0,"ownership":{"direct":true},"balance_after":18000,"source":{"system":"sec-edgar","filing":"0001437749-20-005367","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774920005367/rdgdoc.xml","form_type":"4"}},{"id":3217659,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2020-03-10T20:34:35.000Z","date":"2020-03-10","kind":"purchase","acquired":true,"shares":7657,"price":0.255,"value":1952.535,"ownership":{"direct":true},"balance_after":14000,"source":{"system":"sec-edgar","filing":"0001437749-20-004693","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774920004693/rdgdoc.xml","form_type":"4"}},{"id":3217658,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2020-03-10T20:34:35.000Z","date":"2020-03-10","kind":"purchase","acquired":true,"shares":10,"price":0.2525,"value":2.525,"ownership":{"direct":true},"balance_after":6343,"source":{"system":"sec-edgar","filing":"0001437749-20-004693","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774920004693/rdgdoc.xml","form_type":"4"}},{"id":3217657,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2020-03-10T20:34:35.000Z","date":"2020-03-09","kind":"purchase","acquired":true,"shares":333,"price":0.25,"value":83.25,"ownership":{"direct":true},"balance_after":6333,"source":{"system":"sec-edgar","filing":"0001437749-20-004693","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774920004693/rdgdoc.xml","form_type":"4"}},{"id":3284506,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-08T02:38:23.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). 50% of the shares underlying the option will vest upon the approval by the U.S. Food and Drug Administration of a new drug application for the Company's product candidate, KP415. The remaining 50% of the shares underlying the option will vest upon the approval of a label for KP415 which includes 30 minute onset and 13-hour duration (the \"30/13 Label\") as defined in the KP415 License Agreement dated September 3, 2019. Each vesting event is contingent upon such optionee's continued employment with the Issuer at the relevant vesting date as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant."}],"balance_after":60000,"derivative":{"exercise_price":0.374,"expiration_date":"2030-02-04","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001437749-20-002098","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774920002098/rdgdoc.xml","form_type":"4"}},{"id":3357354,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Stock Option (right to buy)","published_at":"2019-11-27T21:15:19.000Z","date":"2019-11-25","kind":"grant","acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). 100% of the shares underlying the option will vest upon the acceptance of a new drug application for the Company's product candidate, KP415, by the U.S. Food and Drug Administration, provided that at the relevant vesting date such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant."}],"balance_after":36000,"derivative":{"exercise_price":0.5161,"expiration_date":"2029-11-24","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001437749-19-023643","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774919023643/rdgdoc.xml","form_type":"4"}},{"id":3406283,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2019-09-26T00:57:47.000Z","date":"2019-09-24","kind":"purchase","acquired":true,"shares":3000,"price":0.74,"value":2220.0,"ownership":{"direct":true},"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001437749-19-019060","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774919019060/rdgdoc.xml","form_type":"4"}},{"id":3667972,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-08T22:36:57.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). 25% of the shares will vest on February 6, 2020 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant."}],"balance_after":60000,"derivative":{"exercise_price":2.66,"expiration_date":"2029-02-05","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001437749-19-002170","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774919002170/rdgdoc.xml","form_type":"4"}},{"id":3790611,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2018-10-15T20:28:48.000Z","date":"2018-10-12","kind":"purchase","acquired":true,"shares":1500,"price":2.5,"value":3750.0,"ownership":{"direct":true},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001437749-18-018301","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774918018301/rdgdoc.xml","form_type":"4"}},{"id":3790610,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Common Stock","published_at":"2018-10-15T20:28:48.000Z","date":"2018-10-11","kind":"purchase","acquired":true,"shares":1500,"price":2.55,"value":3825.0,"ownership":{"direct":true},"balance_after":1500,"source":{"system":"sec-edgar","filing":"0001437749-18-018301","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774918018301/rdgdoc.xml","form_type":"4"}},{"id":4086465,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":43152,"kind":"person","name":"Sangiovanni Timothy J.","position":1,"cik":"0001698328","reported_name":"Sangiovanni Timothy J.","relationship":{"officer":true,"officer_title":"VP, Corporate Controller"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-29T23:57:14.000Z","date":"2018-01-25","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). 25% of the shares will vest on January 25, 2019 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant."}],"balance_after":30000,"derivative":{"exercise_price":5.5,"expiration_date":"2028-01-24","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-18-001307","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774918001307/rdgdoc.xml","form_type":"4"}}]}